CXCL10, CCL13, SAA1, and CCL27 were more highly expressed in elderly, high‐grade, 1p19q non‐codel, IDH‐wildtype glioma patients, while SSTR5, CCL21, and HTR1A expressions were low in these malignant clinicopathological features of gliomas. This evidence concerns the gene CCL13 and central nervous system cancer.